Ernexa Therapeutics Inc. — DEFA14A Filings
18 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Ernexa Therapeutics Inc. (ERNAW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Ernexa Therapeutics Inc. has filed 18 DEFA14A documents with the SEC since 2009. To view all SEC filings by Ernexa Therapeutics Inc., see the full filings list.
All
10-K
10-K/A
10-K405
10-Q
10-Q/A
15-12G
25
3
3/A
4
4/A
424B3
424B5
425
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DEFS14A
DRS
EFFECT
NT 10-K
NT 10-K/A
NT 10-Q
POS AM
PRE 14A
PRES14A
REGDEX
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001140361-23-023733 | May 10, 2023 | — |
| DEFA14A | DEFA14A | 0001140361-23-023075 | May 5, 2023 | — |
| DEFA14A | DEFA14A | 0001140361-22-029435 | Aug 12, 2022 | — |
| DEFA14A | DEFA14A | 0001140361-22-021149 | May 31, 2022 | — |
| DEFA14A | FORM DEFA14A | 0001140361-22-015989 | Apr 26, 2022 | — |
| DEFA14A | DEFA14A | 0001140361-21-029039 | Aug 20, 2021 | — |
| DEFA14A | FORM DEFA14A | 0001140361-21-025611 | Jul 26, 2021 | — |
| DEFA14A | DEFA14A | 0001140361-21-023202 | Jul 1, 2021 | — |
| DEFA14A | — | 0001493152-19-006001 | Apr 26, 2019 | — |
| DEFA14A | — | 0001493152-18-005874 | Apr 27, 2018 | — |
| DEFA14A | — | 0001493152-17-004544 | Apr 28, 2017 | — |
| DEFA14A | — | 0001493152-16-009132 | Apr 22, 2016 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001019687-15-001601 | Apr 24, 2015 | — |
| DEFA14A | NTN BUZZTIME | 0001019687-14-001543 | Apr 25, 2014 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001019687-13-001737 | May 10, 2013 | — |
| DEFA14A | ADDITIONAL MATERIALS | 0001019687-13-001320 | Apr 12, 2013 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001193125-08-126855 | Jun 3, 2008 | — |
| DEFA14A | DEFA14A | 0001193125-08-125359 | May 30, 2008 | — |